BioSpace News Archive

AmerisourceBergen Corporation reported that in its fiscal year 2022 fourth quarter ended September 30, 2022, revenue increased 3.8 percent to $61.2 billion.

InfuSystem Holdings, Inc. and Sanara MedTech Inc. announced the establishment of a partnership, SI Wound Care, LLC, focused on delivering a complete wound care solution targeted at improving patient outcomes, lowering the cost of care, and increasing patient and provider satisfaction.

Mallinckrodt plc announced that seven scientific abstracts on clinical and health economic outcomes research on treatment with TERLIVAZ® for adult patients with hepatorenal syndrome involving rapid reduction in kidney function,1 an acute and life-threatening condition requiring hospitalization2 will be presented at the American Association for the Study of Liver Diseases 2022 Liver Meeting in Washington, DC, from November 4-8.

ProQR Therapeutics N.V., a company dedicated to changing lives through the creation of transformative RNA therapies, announced that Company management will participate in the Stifel 2022 Healthcare Conference.

Athenex, Inc. announced that a Nasdaq Hearings Panel has granted the company’s request for continued listing on The Nasdaq Stock Market, subject to the Company’s satisfaction of the minimum $1.00 bid price requirement by March 14, 2023.

Helius Medical Technologies will showcase its innovative new Portable Neuromodulation Stimulator at the 99th annual American Congress of Rehabilitation Medicine Conference, held November 8-11 in Chicago.

Amryt provides a business update and announces unaudited financial results for the third quarter ended September30, 2022.

Kymera Therapeutics, Inc. reported business highlights and financial results for the third quarter ended September 30, 2022.

VectivBio Holding AG announced the completion of enrollment of the Colon-in-Continuity cohort for the company’s Phase 3 STARS pivotal study investigating the long-acting synthetic GLP-2 agonist apraglutide in Short Bowel Syndrome with Intestinal Failure.

Athenex, Inc. provided a corporate and financial update for the third quarter ended September 30, 2022.